AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Trivogo 1/0.3mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Alembic Pharmaceuticals Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Trivogo 1/0.3mg Tablet SR

Glycemic control in adults with type 2 diabetes mellitus is achieved with the anti-diabetic medication, Trivogo 1/0.3mg SR tablets. This dual-action formulation manages blood glucose levels. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined individually by your physician and may be adjusted based on your blood glucose monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan encompassing a balanced diet, physical activity, and weight management as directed by your healthcare provider. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to counteract them with fast-acting glucose sources (e.g., sugary foods or juice). Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, upper respiratory infections, and weight gain. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or breastfeeding individuals must consult their doctor before use. Regular blood glucose monitoring is essential, and your doctor may recommend blood tests to monitor blood cell counts and liver function.

Uses of Trivogo 1/0.3mg Tablet SR

Managing type 2 diabetes

Major Benefits of Trivogo 1/0.3mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Trivogo 1/0.3mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.

Common Side effects of Trivogo 1/0.3mg Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Trivogo 1/0.3mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Trivogo 1/0.3mg Tablet SR on an empty stomach.

How Trivogo 1/0.3mg Tablet SR works:

Trivogo SR tablets (1/0.3mg) contain a triple-drug formulation for diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol consumption and Trivogo 1/0.3mg Tablet SR is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Trivogo 1/0.3mg sustained-release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Consult your physician for advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Trivogo 1/0.3mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

Employing Trivogo 1/0.3mg Tablet SR is likely inadvisable for individuals with impaired renal function and should be omitted. Medical advice is recommended. Furthermore, this medication is not suggested for patients exhibiting severely compromised kidney function.

LiverLiverCAUTION

Patients with liver impairment should use Trivogo 1/0.3mg Tablet SR cautiously, potentially requiring dosage modification. Consult a physician. A reduced initial dose is typically prescribed for individuals with mild to moderate hepatic dysfunction; the medication is contraindicated in those with severe liver disease.

What if you forget to take Trivogo 1/0.3mg Tablet SR :

Should you forget to take a Trivogo 1/0.3mg Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Trivogo 1/0.3mg Tablet SR

LabelValue
Addictive None.
Medication Category Medication for diabetes

FAQs on Trivogo 1/0.3mg Tablet SR

Trivogo 1/0.3mg Extended-Release tablets contain glimepiride, metformin, and voglibose. This medication manages type 2 diabetes mellitus in adults, enhancing blood glucose control when combined with a suitable diet and regular physical activity. Glimepiride stimulates pancreatic insulin secretion to reduce blood sugar. Metformin decreases hepatic glucose production and improves insulin responsiveness. Voglibose, an alpha-glucosidase inhibitor, reduces post-meal glucose levels. This formulation is unsuitable for type 1 diabetes treatment.
Taking Trivogo 1/0.3mg Tablet SR may cause common adverse reactions including low blood sugar, nausea, diarrhea, changes in taste perception, gas, abdominal pain, headache, skin eruptions, and respiratory illness.
Patients with hypersensitivity to Trivogo 1/0.3mg Tablet SR constituents or inactive ingredients should not take this medication. Its use is contraindicated in individuals with moderate to severe nephropathy, and those suffering from inflammatory bowel disorders, colonic lesions, or underlying metabolic acidosis, such as diabetic ketoacidosis.
Combining Trivogo 1/0.3mg Tablet SR with alcohol is unsafe. This combination can reduce blood sugar to dangerously low levels (hypoglycemia) and heighten the risk of lactic acidosis.
Indeed, Trivogo 1/0.3mg Extended-Release Tablets can induce hypoglycemia. Low blood sugar symptoms may present as nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of unease or tremor. These symptoms are more likely if meals are skipped or delayed, alcohol is consumed, excessive physical activity occurs, or other diabetes medications are concurrently used. Consequently, consistent blood glucose monitoring is crucial. It's advisable to keep readily available sources of glucose, such as glucose tablets, honey, or fruit juice, on hand.
Retain this medication within its original, sealed packaging. Follow the storage guidelines printed on the packaging or label. Discard any leftover medication. Prevent access by children, pets, and other individuals.
Trivogo 1/0.3mg Tablet SR
123
MRP 150
18% off